Newsroom

Industry News

9 Feb

PCG Advisory Group Appoints Howard Gostfrand as Senior Advisor

NEW YORK, NY / ACCESSWIRE / February 9, 2017 / PCG Advisory Group, a New York-based leading investor and public relations firm, today announced that it has appointed Howard Gostfrand, President of American Capital Ventures, as a Senior Advisor. “Howard Gostfrand’s experience and ties to the investment community will...

Read more

9 Feb

Actinium Pharmaceuticals to Present at BIO CEO & Investor Conference

NEW YORK, Feb. 09, 2017 (GLOBE NEWSWIRE) — Actinium Pharmaceuticals, Inc.  (NYSE MKT:ATNM) (“Actinium” or “the Company”), a biopharmaceutical company developing innovative targeted therapies for cancers lacking effective treatment options, announced today that Sandesh Seth, Actinium’s Executive Chairman, will be presenting at the BIO CEO & Investor Conference being...

Read more

8 Feb

IsoRay Announces Second Quarter Fiscal 2017 Financial Results

RICHLAND, Wash., Feb. 8, 2017 /PRNewswire/ –­­ IsoRay, Inc. (NYSE MKT: ISR), a medical technology company and innovator in seed brachytherapy and medical radioisotope applications for the treatment of prostate, brain, lung, head and neck and gynecological cancers, today announced financial results for the second quarter of fiscal 2017, ended December...

Read more

8 Feb

OncoSec to Present New Clinical Data from Phase 2 Combination Study at ASCO-SITC Clinical Immuno-Oncology Symposium and Corporate Updates at Two Investment Conferences in February

SAN DIEGO, Feb. 8, 2017 /PRNewswire/ — OncoSec Medical Incorporated (“OncoSec”) (ONCS), a company developing DNA-based intratumoral cancer immunotherapies, will present new clinical data on ImmunoPulse® IL-12, its lead program focused on oncology, at the upcoming 2017 American Association for Cancer Research & Society for Immunotherapy of Cancer (ASCO-SITC) Clinical...

Read more

7 Feb

Monster Digital, Inc. Announces New Management Appointments

SIMI VALLEY, CA–(Marketwired – Feb 7, 2017) – Monster Digital, Inc. ( NASDAQ : MSDI ) (“Monster Digital” or the “Company”), which develops, markets and distributes a line of sports action cameras, a 360 Virtual Reality camera and related VR Goggles under the Monster Digital brand, today announced new...

Read more

7 Feb

CymaBay Therapeutics to Present at the 2017 BIO CEO & Investor Conference

NEWARK, Calif., Feb. 07, 2017 (GLOBE NEWSWIRE) — CymaBay Therapeutics, Inc. (CBAY), a clinical-stage biopharmaceutical company developing therapies to treat specialty and orphan diseases with high unmet medical need, today announced that management will provide a corporate overview at the BIO CEO & Investor Conference, being held on February...

Read more

Page 4 of 216« First...23456...102030...Last »

Enter your email address to receive notifications of new posts by email.

Latest Tweets

Follow

Follow this blog

Get every new post delivered right to your inbox.

Email address